Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
CEL-SCI history
CEL-SCI company history timeline
The company went public in the year of its founding, 1983.
In May 1992, the United States Securities and Exchange Commission issued a cease and desist order against the company's then-President, Maximilian de Clara.
Geert Kersten, de Clara's stepson, has been the company's CEO since 1995.
In 1997, Cel-Sci bought a technology which enabled regulation of immune system responses that they had been licensing from the Dutch company Sittona.
The New York Times reported that in 1999, Cel-Sci received an unsolicited cash offer of $124 million from an unidentified person in Argentina.
Later, the FDA lifted their clinical hold imposed on Cel-Sci in August 2017.
On February 26, 2020, Cel-Sci's stock dropped 42.4% before a trading halt was issued for news pending.
On June 28, 2021, Cel-Sci announced that the study missed its primary endpoint as the higher risk subgroup did not achieve a 10% improvement in overall survival even though the lower risk subgroup did.
Rate CEL-SCI's efforts to communicate its history to employees.
CEL-SCI jobs
Do you work at CEL-SCI?
Is CEL-SCI's vision a big part of strategic planning?
CEL-SCI competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Genentech | 1976 | $166.9M | 13,638 | 524 |
| Baxter International | 1931 | $10.6B | 48,000 | 161 |
| Gilead Sciences | 1987 | $28.8B | 11,800 | 582 |
| ImClone Systems LLC | 1984 | $39.0M | 180 | - |
| Medimmune | 1987 | $422.2M | 6,030 | - |
| CIMA Labs | 1986 | $8.5M | 120 | 17 |
| Martek Biosciences | 1985 | $450.0M | 600 | - |
| Immucor | 1982 | $380.0M | 1,125 | - |
| MannKind | 1991 | $10.0M | 233 | 26 |
| Ethicon | 1915 | $4.9B | 11,000 | - |
CEL-SCI history FAQs
Zippia gives an in-depth look into the details of CEL-SCI, including salaries, political affiliations, employee data, and more, in order to inform job seekers about CEL-SCI. The employee data is based on information from people who have self-reported their past or current employments at CEL-SCI. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by CEL-SCI. The data presented on this page does not represent the view of CEL-SCI and its employees or that of Zippia.
CEL-SCI may also be known as or be related to CEL SCI CORP, CEL-SCI, CEL-SCI Corp., CEL-SCI Corporation and Cel-Sci.